SEC Form 4 · accession 0001140361-18-035061
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hollingshead
Officer — President, Sleep Business
Period of report
Aug 1, 2018
Accepted (ET)
Aug 2, 2018 · 1:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Aug 1, 2018 | S | 600 | $105.93 | D | 59,663 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was conducted under a Rule10b5-1 Plan.